Literature DB >> 15288842

Important prognostic factors of long-term oropharyngeal carcinoma survivors in Taiwan.

Ping-Ho Chen1, Ying-Chin Ko, Yi-Hsin Yang, Ying-Chu Lin, Tien-Yu Shieh, Chung-Ho Chen, Chi-Cheng Tsai.   

Abstract

In Taiwan, a clear gender difference emerges for rates of oropharyngeal carcinoma incidence. The purpose of this study was to identify the gender differences and clinical factors associated with oropharyngeal carcinoma survival rates in Taiwan. We analyzed the 5-year survival rates of 8114 subjects diagnosed with oropharyngeal carcinoma between 1987 and 1994. The Cox proportional-hazards model identified clinical characteristics for gender according to oropharyngeal carcinoma death and all-cause death outcomes. The 5-year survival rates were significantly lower for males than females (p < 0.0001). The adjusted hazard ratio of males versus females was 1.54 (95% CI: 1.36-1.74) for oropharyngeal carcinoma death and 1.44 (95% CI: 1.31-1.58) for all-cause death. Gender and other clinical characteristics (i.e. diagnostic age, anatomic site, morphologic type, and treatment modality) play important roles in oropharyngeal carcinoma survival. We suggested that Taiwanese males have high proportion of betel quid chewing and that this is associated with the gender differences.

Entities:  

Mesh:

Year:  2004        PMID: 15288842     DOI: 10.1016/j.oraloncology.2004.03.006

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma.

Authors:  Hui-Ching Chuang; Chang-Han Chen; Chao-Cheng Huang; Fu-Min Fang; Hsin-Ting Tsai; Chih-Yen Chien
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

2.  Incidence of oral cancer in relation to nickel and arsenic concentrations in farm soils of patients' residential areas in Taiwan.

Authors:  Che-Chun Su; Yo-Yu Lin; Tsun-Kuo Chang; Chi-Ting Chiang; Jian-An Chung; Yun-Ying Hsu; Ie-Bin Lian
Journal:  BMC Public Health       Date:  2010-02-12       Impact factor: 3.295

3.  A Comprehensive Cross-Tabulation Analysis of Oral Carcinoma Patients: A Retrospective Study of Recent 7 Years.

Authors:  Wan Muhamad Amir W Ahmad; Farah Muna Mohamad Ghazali; Muhammad Azeem Yaqoob; Ghazi Hamad Alawthah; Kumar Chandan Srivastava; Deepti Shrivastava; Mohammad Khursheed Alam
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

4.  Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan.

Authors:  Ping-Ho Chen; Tien-Yu Shieh; Pei-Shan Ho; Chi-Cheng Tsai; Yi-Hsin Yang; Ying-Chu Lin; Min-Shan Ko; Pei-Chien Tsai; Shang-Lun Chiang; Hung-Pin Tu; Ying-Chin Ko
Journal:  BMC Cancer       Date:  2007-06-15       Impact factor: 4.430

Review 5.  Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.

Authors:  Che-Yi Lin; Tien-Szu Pan; Chun-Chan Ting; Shih-Shin Liang; Shu-Hung Huang; Hsiu-Yueh Liu; Edward Cheng-Chuan Ko; Chung-Wei Wu; Jen-Yang Tang; Ping-Ho Chen
Journal:  ScientificWorldJournal       Date:  2013-08-01

6.  Cancers of upper gingivobuccal sulcus, hard palate and maxilla: A tertiary care centre study in North India.

Authors:  Vijay Kumar; V A Sindhu; Sivaprakash Rathanaswamy; Jaswant Jain; Jaipalreddy R Pogal; Naseem Akhtar; Sameer Gupta
Journal:  Natl J Maxillofac Surg       Date:  2013-07

Review 7.  Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.

Authors:  Ping-Ho Chen; Qaisar Mahmood; Gian Luigi Mariottini; Tai-An Chiang; Ka-Wo Lee
Journal:  Biomed Res Int       Date:  2017-12-11       Impact factor: 3.411

Review 8.  Micro-RNAs: Crossroads between the Exposure to Environmental Particulate Pollution and the Obstructive Pulmonary Disease.

Authors:  Mauro Finicelli; Tiziana Squillaro; Umberto Galderisi; Gianfranco Peluso
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.